These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 14739907)

  • 1. LIFE and SCOPE: what guidance do they offer alongside ALLHAT and ANBP2?
    Nicholls MG
    J Hum Hypertens; 2004 May; 18(5):295-300. PubMed ID: 14739907
    [No Abstract]   [Full Text] [Related]  

  • 2. Selecting antihypertensive medication in patients with essential hypertension in Malaysia.
    Ong HT; Rozina G
    Med J Malaysia; 2009 Mar; 64(1):3-11. PubMed ID: 19852313
    [No Abstract]   [Full Text] [Related]  

  • 3. Safety and efficacy of first-line antihypertensives.
    Strickland C
    J Fam Pract; 1997 Jun; 44(6):530-1. PubMed ID: 9191619
    [No Abstract]   [Full Text] [Related]  

  • 4. [Clinical trials on protective efficacy of antihypertensive agents for organ damage due to diabetes mellitus complicated with hypertension].
    Higashiura K
    Nihon Rinsho; 2004 Mar; 62 Suppl 3():623-7. PubMed ID: 15171446
    [No Abstract]   [Full Text] [Related]  

  • 5. The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack (ALLHAT) Trial: focus on the diabetic patient.
    Berecek KH; Farag A; Bahtiyar G; Rothman J; McFarlane SI
    Curr Hypertens Rep; 2004 Jun; 6(3):212-4. PubMed ID: 15128474
    [No Abstract]   [Full Text] [Related]  

  • 6. Prescribing patterns for antihypertensive drugs after the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial: report of experience in a health maintenance organization.
    Xie F; Petitti DB; Chen W
    Am J Hypertens; 2005 Apr; 18(4 Pt 1):464-9. PubMed ID: 15831354
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Interview with Prof. Peter Dominiak, Lübeck. "Risk of diabetes with antihypertensive drugs is clinically relevant" (interview by Dr. Angelika Bischoff)].
    Dominiak P
    MMW Fortschr Med; 2004 Dec; 146(51-52):51. PubMed ID: 15675248
    [No Abstract]   [Full Text] [Related]  

  • 8. ALLHAT findings revisited in the context of subsequent analyses, other trials, and meta-analyses.
    Onuigbo MA
    Arch Intern Med; 2009 Oct; 169(19):1810; author reply 1810-1. PubMed ID: 19858442
    [No Abstract]   [Full Text] [Related]  

  • 9. [ALLHAT=other leading physicians have alternative interpretations].
    Charles A
    Lakartidningen; 2003 Jun; 100(23):2073-4. PubMed ID: 12833745
    [No Abstract]   [Full Text] [Related]  

  • 10. Back to basics: diuretics as first-line agents in the treatment of hypertension.
    Mandal VJ
    J Am Geriatr Soc; 2004 Jul; 52(7):1210-1. PubMed ID: 15209664
    [No Abstract]   [Full Text] [Related]  

  • 11. [Management of hypertension in upheaval?].
    Zidek W; Paul M
    Dtsch Med Wochenschr; 2005 Nov; 130(46):2627. PubMed ID: 16281156
    [No Abstract]   [Full Text] [Related]  

  • 12. Treatment of hypertension.
    Cuddy ML
    J Pract Nurs; 2006; 56(1):11-5; quiz 18-9. PubMed ID: 16704189
    [No Abstract]   [Full Text] [Related]  

  • 13. Comparison between angiotensin-converting enzyme inhibitors and angiotensin receptor blockers on the risk of myocardial infarction, stroke and death: a meta-analysis.
    Reboldi G; Angeli F; Cavallini C; Gentile G; Mancia G; Verdecchia P
    J Hypertens; 2008 Jul; 26(7):1282-9. PubMed ID: 18550998
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Are newer antihypertensive agents better than the older ones? Results of trials (CAPPP, STOP-2, NORDIL, INSIGHT and ALLHAT) with newer antihypertensive agents].
    Hildebrandt PR; Tuxen CD; Kjeldsen SE; Lund-Johansen P; Hansson L
    Ugeskr Laeger; 2001 Dec; 164(1):18-21. PubMed ID: 11810791
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Not all antihypertensive agents protect equally well].
    MMW Fortschr Med; 2006 Aug; 148(33-34):52. PubMed ID: 16981390
    [No Abstract]   [Full Text] [Related]  

  • 16. A comparison between persistence to therapy in ALLHAT and in everyday clinical practice: a generalizability issue.
    Cardinal H; Monfared AA; Dorais M; LeLorier J
    Can J Cardiol; 2004 Mar; 20(4):417-21. PubMed ID: 15057318
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of beta-blockers up for debate.
    Virk IS
    Postgrad Med; 2004 Jul; 116(1):8-9; author reply 9. PubMed ID: 15274284
    [No Abstract]   [Full Text] [Related]  

  • 18. The design of ALLHAT may have biased the study's outcome in favor of the diuretic cohort.
    Hebert LA; Rovin BH; Hebert CJ
    Nat Clin Pract Nephrol; 2007 Feb; 3(2):60-1. PubMed ID: 17251990
    [No Abstract]   [Full Text] [Related]  

  • 19. [Pharmacological hypertension therapy].
    Pedersen OL; Christensen KL; Bang LE; Ibsen H; Schultz-Larsen P
    Ugeskr Laeger; 2009 Jun; 171(24):2022-5. PubMed ID: 19523367
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Benefits and risks of combination therapy in hypertension.
    Node K
    Hypertens Res; 2009 Sep; 32(9):727-8. PubMed ID: 19609269
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.